Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival

Suzanne Merrill, Brian S. Sohl, Ashiya Hamirani, Erik B. Lehman, Kathleen K. Lehman, Matthew G. Kaag, Jay Raman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

It remains unclear if surveillance of renal cell carcinoma (RCC) affords a survival benefit. Using 737 post-nephrectomy patients with M0 RCC, we examined whether detecting asymptomatic versus symptomatic recurrences influences mortality. Multivariable analysis showed that symptomatic recurrences were associated with a 3-fold increased risk of both overall and disease-specific mortality. These findings support that RCC surveillance provides beneficial patient outcomes.

Original languageEnglish (US)
Pages (from-to)132-138
Number of pages7
JournalClinical Genitourinary Cancer
Volume17
Issue number2
DOIs
StatePublished - Apr 1 2019

Fingerprint

Renal Cell Carcinoma
Recurrence
Survival
Mortality
Nephrectomy

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology

Cite this

Merrill, Suzanne ; Sohl, Brian S. ; Hamirani, Ashiya ; Lehman, Erik B. ; Lehman, Kathleen K. ; Kaag, Matthew G. ; Raman, Jay. / Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival. In: Clinical Genitourinary Cancer. 2019 ; Vol. 17, No. 2. pp. 132-138.
@article{bfe58d8a318b4fa6a838533f5858baef,
title = "Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival",
abstract = "It remains unclear if surveillance of renal cell carcinoma (RCC) affords a survival benefit. Using 737 post-nephrectomy patients with M0 RCC, we examined whether detecting asymptomatic versus symptomatic recurrences influences mortality. Multivariable analysis showed that symptomatic recurrences were associated with a 3-fold increased risk of both overall and disease-specific mortality. These findings support that RCC surveillance provides beneficial patient outcomes.",
author = "Suzanne Merrill and Sohl, {Brian S.} and Ashiya Hamirani and Lehman, {Erik B.} and Lehman, {Kathleen K.} and Kaag, {Matthew G.} and Jay Raman",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.clgc.2018.11.009",
language = "English (US)",
volume = "17",
pages = "132--138",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "2",

}

Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival. / Merrill, Suzanne; Sohl, Brian S.; Hamirani, Ashiya; Lehman, Erik B.; Lehman, Kathleen K.; Kaag, Matthew G.; Raman, Jay.

In: Clinical Genitourinary Cancer, Vol. 17, No. 2, 01.04.2019, p. 132-138.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival

AU - Merrill, Suzanne

AU - Sohl, Brian S.

AU - Hamirani, Ashiya

AU - Lehman, Erik B.

AU - Lehman, Kathleen K.

AU - Kaag, Matthew G.

AU - Raman, Jay

PY - 2019/4/1

Y1 - 2019/4/1

N2 - It remains unclear if surveillance of renal cell carcinoma (RCC) affords a survival benefit. Using 737 post-nephrectomy patients with M0 RCC, we examined whether detecting asymptomatic versus symptomatic recurrences influences mortality. Multivariable analysis showed that symptomatic recurrences were associated with a 3-fold increased risk of both overall and disease-specific mortality. These findings support that RCC surveillance provides beneficial patient outcomes.

AB - It remains unclear if surveillance of renal cell carcinoma (RCC) affords a survival benefit. Using 737 post-nephrectomy patients with M0 RCC, we examined whether detecting asymptomatic versus symptomatic recurrences influences mortality. Multivariable analysis showed that symptomatic recurrences were associated with a 3-fold increased risk of both overall and disease-specific mortality. These findings support that RCC surveillance provides beneficial patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85058413855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058413855&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2018.11.009

DO - 10.1016/j.clgc.2018.11.009

M3 - Article

C2 - 30563753

AN - SCOPUS:85058413855

VL - 17

SP - 132

EP - 138

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 2

ER -